Skip to main content

Apyx Medical Corp(APYX-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

RENUVION® RECEIVES FDA CLEARANCE FOR SPECIFIC USE AFTER LIPOSUCTION

PR Newswire - Tue May 2, 2023

APYX Medical's Renuvion Becomes the Only Device that is FDA-cleared for Use Following Liposuction in Aesthetic Body Contouring Procedures

CLEARWATER, Fla., May 2, 2023 /PRNewswire/ -- Apyx Medical Corporation (NASDAQ: APYX), the manufacturer of the proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA") for the use of its APR Handpiece in procedures for coagulation of soft tissues following liposuction, the most popular plastic surgery procedure in the world.

Read more at prnewswire.com

Provided Content: Content provided by PR Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe

watchlist
25 stocks most added to Watchlists